Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly

European Respiratory Journal, Supplement

Volumn 21, Issue 40, 2003, Pages

  Lundback B ^a,b   Gulsvik, A ^c   Albers, M ^d   Bakke, P ^c   Ronmark E ^b,e   Van den Boom, G ^d   Brogger J ^c   Larsson, L G ^b   Welle, I ^c   Van Weel, C ^d   Omenaas, E ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SUNDERBY HOSPITAL   (Sweden)

^c UNIVERSITY OF BERGEN   (Norway)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UMEÅ UNIVERSITY   (Sweden)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Epidemiology; Spirometry

Indexed keywords

AGE; AGED; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DISABILITY; DISEASE SEVERITY; EARLY DIAGNOSIS; FORCED EXPIRATORY VOLUME; HUMAN; INCIDENCE; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REMISSION; SCREENING; SMOKING; EUROPE; MASS SCREENING; REVIEW; SPIROMETRY;

AGED; ASTHMA; DISABILITY EVALUATION; EUROPE; HUMANS; INCIDENCE; MASS SCREENING; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY;

EID: 0037542773     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-1420.
2. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: Suppl. 5, S77-S120.
3. British Thoracic Society. British Thoracic Society guidelines for the management of chronic obstructive pulmonary disease. Thoracic 1997; 52: Suppl. 5, S1-S28.
4. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Am J Respir Crit Care Med 2001; 46: 798-825.
5. Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med 1991; 85: Suppl. B, 25-31.
6. Tirimanna PR, van Schayck CP, den Otter JJ, et al. Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977? Br J Gen Pract 1996; 46: 277-281.
7. Lindström M, Jönsson E, Larsson K, Lundbäck B. Underdiagnosis of chronic obstructive pulmonary disease in Northern Sweden. Int J Tuberc Lung Dis 2002; 6: 76-84.
8. Engström CP, Persson LO, Larson S, Sullivan M. Health-related quality of life in COPD: Why both disease-specific and generic measures should be used. Eur Respir J 2001; 18: 69-76.
9. Lundbäck B. Epidemiology of rhinitis and asthma. Clin Exp Allergy 1998; 28: Suppl. 2, 3-10.
10. Rönmark E, Jönsson E, Lundbäck B. Remission of asthma in the middle aged and elderly: report from the Obstructive Lung Disease in Northern Sweden study. Thorax 1999; 54: 611-613.
11. Weiss KB. An Overview of recent trends in asthma epidemiology. Eur Respir Rev 1996; 6: 35, 101-104.
12. Murray CJL, Lopez AD, eds. The Global Burden of Disease. A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Publication from the Harvard School of Public Health on behalf of The World Health Organization and the World Bank. Cambridge, MA, Harvard University Press, 1996.
13. Van Weel C, Smith H, Beasley JW. Family practice research networks. Experience from three countries. J Fam Pract 2000; 49: 938-943.
14. Van Weel C. Ethics of health care for the elderly. Longevity, aging and the demand of primary care. In: Butler RN, Jasmin C, eds. Longevity and Quality of Life. Opportunities and Challenges. New York, Kluwer/Plenum, 2000.
15. Fletcher CM, Gilson JH, Hugh-Jones P, Schadding JG. Terminology, definitions and classification of chronic pulmonary emphysema and related conditions. A report of the conclusions of the CIBA guest symposium. Thorax 1959; 14: 286-299.
16. Roca J, Burgos F, Sunyer J, et al. Reference values for forced spirometry. Eur Respir J 1998; 11: 1354-1362.
17. Heederik D, Kromhout H, Kromhout D, Burema J, Bierstecker K. Relationship between occupational smoking, lung function, and incidence and mortality of chronic nonspecific lung disease: The Zutphen study. Br J Ind Med 1992; 49: 299-308.
18. Viegi G, Pedreschi M, Pistelli F, et al. Prevalence of airways obstruction in a general population. European Respiratory Society vs American Thoracic Society definition. Chest 2000; 117: Suppl. 2, 339S-345S.
19. Gulsvik A. Prevalence and manifestations of obstructive lung disease in the city of Oslo. Scand J Resp Dis 1979; 60: 286-296.
20. Lange P, Groth S, Nyboe J, et al. Chronic obstructive lung disease in Copenhagen: cross-sectional epidemiological aspects. J Intern Med 1989; 226: 25-32.
21. Bakke PS, Baste V, Hanoa R, Gulsvik A. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax 1991; 46: 863-870.
22. Isoaho R, Puolijoka H, Huhti E, Kivela SL, Laippala P, Tala E. Prevalence of chronic obstructive pulmonary disease in elderly Finns. Respir Med 1994; 88: 571-580.
23. Lundbäck B, Lindberg A, Lindström M, et al. Not 15 but 50% of smokers develop COPD? - Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97: 115-122.
24. Strachan D. Epidemiology: A British perspective. In: Calverly P, Pride N, eds. Chronic Obstructive Pulmonary Disease. London, Chapman & Hall, 1995; pp. 47-67.
25. Sobradillo V, Miravitles M, Jiménez CA, et al. Epidemiological study in chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation. Arch Broncopneumol 1999; 35: 159-166.
26. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States. Data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160: 1683-1689.
27. Stang P, Lydick E, Silberman C, Kempel A, Keating ET. The prevalence of COPD: Using smoking rates to estimate disease frequency in the general population. Chest 2000; 117: Suppl. 2, 354S-359S.
28. National Center for Health Statistics. Vital and Health Statistics. Series 10, No. 199. Washington, DC, Government Printing Office, 1998.
29. Murray CJL, Lopez AD, eds. Global Health Statistics. A compendium of incidence, prevalence and mortality estimates for over 200 conditions. Publication from the Harvard School of Public Health on behalf of the World Health Organization and the World Bank. Cambridge, MA, Harvard University Press, 1996.
30. Huhti E, Ikkala J. A follow-up study on respiratory symptoms and ventilatory function in a middle-ages rural population. Eur J Respir Dis 1980; 61: 33-45.
31. Humerfelt S, Gulsvik A, Skjærven R, et al. Decline in FEV1 and airflow limitation related to occupational exposures in men of an urban community. Eur Respir J 1993; 6: 1095-1103.
32. Heederik D, Kromhout H, Burema J, Bieerstecker K, Kromhout D. Occupational exposure and 25 years incidence rate of non-specific lung disease - the Zutphen study. Int J Epidemiol 1990; 19: 945-952.
33. Krzyzanowski M, Jedrychowski W, Wysocki M. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow up of the Cracow study. Am Rev Respir Dis 1986; 134: 1011-1019.
34. Murray CJL, AD Lopez. Alternative visions of the future: projecting mortality and disability, 1990-2020. In: Murray CJL, AD Lopez, eds. The Global Burden of Disease. A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Publication from the Harvard School of Public Health, on behalf of the World Health Organization and the World Bank. Cambridge, MA, Harvard University Press, 1996; pp. 361-395.
35. Lundbäck B, Rönmark E, Jönsson E, Larsson K, Sandström T. Incidence of physician-diagnosed asthma in adults - a real incidence or a result of increased awareness? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2001; 95: 685-692.
36. Rönmark E, Jönsson E, Platts-Mills T, Lundbäck B. Incidence and remission of asthma in school children - report from the Obstructive Lung Disease in Northern Sweden. Pediatrics 2001; 107: e37.
37. Broder I, Higgins MW, Mathews KP, Keller JB. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. J Allergy Clin Immunol 1974; 54: 100-110.
38. Dodge R, Burrows B. The prevalence and incidence of asthma and asthma-like symptoms in a general population sample. Am Rev Respir Dis 1980; 122: 567-575.
39. Troisi RJ, Speizer FE, Rosner B, Trichopoulus D, Willett WC. Cigarette smoking and incidence of chronic bronchitis and asthma in women. Chest 1995; 108: 1557-1561.
40. McWhorter WP, Polis MA, Kaslow RA. Occurrence, predictors, and consequences of adult asthma in NHANESI and follow-up survey. Am Rev Respir Dis 1989; 139: 721-724.
41. Schachter EN, Doyle CA, Beck GJ. A prospective study of asthma in a rural community. Chest 1984; 85: 623-630.
42. Vesterinen E, Kaprio J, Koskenvou M. Prospective study of asthma in relation to smoking habits among 14,729 adults. Thorax 1988; 43: 534-539.
43. Strachan DP, Butland BK, Anderson HR. Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ 1996; 312: 1195-1199.
44. Toren K, Hermansson BA. Incidence rate of adult-onset asthma in relation to age, sex, atopy and smoking. A Swedish population-based study of 15,813 adults. Int J Tuberc Lung Dis 1999; 3: 192-197.
45. Bronniman S, Burrows B. A prospective study of the natural history of asthma. Remission and relapse rates. Chest 1986; 90: 480-484.
46. Panhuysen CIM, Vonk JM, Koeter GH, et al. Adult patients may outgrow their asthma. A 25-year follow-up study. Am J Respir Crit Care Med 1997; 1551: 1267-1272.
47. Van den Boom G, van Schayck CP, Rutten-van Molken MP, et al. Active detection of chronic obstructive pulmonary disease and asthma in the general population, Results and economic consequences of the DIMCA program. Am J Respir Crit Care Med 1998; 158: 1730-1738.
48. Haahtela T, Jarvinen M, Kava T, et al. Comparison of a beta-2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991; 325: 388-392.
49. Dompeling E, van Schayck CP, van Grunsven PM, et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann Intern Med 1993; 118: 770-778.
50. Van den Boom G, Tirimanna PRS, Kaptein AA, et al. Underpresentation of shortness of breath in the general population: Results of the DIMCA programme. Asthma in Gen Pract 1999; 7: 3-7.